987 related articles for article (PubMed ID: 16436388)
1. Regulation of fibroblast growth factor-23 signaling by klotho.
Kurosu H; Ogawa Y; Miyoshi M; Yamamoto M; Nandi A; Rosenblatt KP; Baum MG; Schiavi S; Hu MC; Moe OW; Kuro-o M
J Biol Chem; 2006 Mar; 281(10):6120-3. PubMed ID: 16436388
[TBL] [Abstract][Full Text] [Related]
2. The Klotho gene family as a regulator of endocrine fibroblast growth factors.
Kurosu H; Kuro-O M
Mol Cell Endocrinol; 2009 Feb; 299(1):72-8. PubMed ID: 19063940
[TBL] [Abstract][Full Text] [Related]
3. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism.
Kuro-o M
Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):437-41. PubMed ID: 16775459
[TBL] [Abstract][Full Text] [Related]
4. Klotho converts canonical FGF receptor into a specific receptor for FGF23.
Urakawa I; Yamazaki Y; Shimada T; Iijima K; Hasegawa H; Okawa K; Fujita T; Fukumoto S; Yamashita T
Nature; 2006 Dec; 444(7120):770-4. PubMed ID: 17086194
[TBL] [Abstract][Full Text] [Related]
5. The Klotho gene family and the endocrine fibroblast growth factors.
Kurosu H; Kuro-o M
Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):368-72. PubMed ID: 18660672
[TBL] [Abstract][Full Text] [Related]
6. FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone.
Wöhrle S; Bonny O; Beluch N; Gaulis S; Stamm C; Scheibler M; Müller M; Kinzel B; Thuery A; Brueggen J; Hynes NE; Sellers WR; Hofmann F; Graus-Porta D
J Bone Miner Res; 2011 Oct; 26(10):2486-97. PubMed ID: 21812026
[TBL] [Abstract][Full Text] [Related]
7. Soluble Klotho causes hypomineralization in Klotho-deficient mice.
Minamizaki T; Konishi Y; Sakurai K; Yoshioka H; Aubin JE; Kozai K; Yoshiko Y
J Endocrinol; 2018 Jun; 237(3):285-300. PubMed ID: 29632215
[TBL] [Abstract][Full Text] [Related]
8. Expression and localization of fibroblast growth factor (FGF)23 and Klotho in the spleen: its physiological and functional implications.
Nakashima Y; Mima T; Yashiro M; Sonou T; Ohya M; Masumoto A; Yamanaka S; Koreeda D; Tatsuta K; Hanba Y; Moribata M; Negi S; Shigematsu T
Growth Factors; 2016 Dec; 34(5-6):196-202. PubMed ID: 28095739
[TBL] [Abstract][Full Text] [Related]
9. Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation.
Goetz R; Nakada Y; Hu MC; Kurosu H; Wang L; Nakatani T; Shi M; Eliseenkova AV; Razzaque MS; Moe OW; Kuro-o M; Mohammadi M
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):407-12. PubMed ID: 19966287
[TBL] [Abstract][Full Text] [Related]
10. Klotho.
Kuro-o M
Pflugers Arch; 2010 Jan; 459(2):333-43. PubMed ID: 19730882
[TBL] [Abstract][Full Text] [Related]
11. In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis.
Nakatani T; Sarraj B; Ohnishi M; Densmore MJ; Taguchi T; Goetz R; Mohammadi M; Lanske B; Razzaque MS
FASEB J; 2009 Feb; 23(2):433-41. PubMed ID: 18835926
[TBL] [Abstract][Full Text] [Related]
12. The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis.
Razzaque MS; Lanske B
J Endocrinol; 2007 Jul; 194(1):1-10. PubMed ID: 17592015
[TBL] [Abstract][Full Text] [Related]
13. Toward a better understanding of Klotho.
Nabeshima Y
Sci Aging Knowledge Environ; 2006 May; 2006(8):pe11. PubMed ID: 16672727
[TBL] [Abstract][Full Text] [Related]
14. FGF23 beyond Phosphotropic Hormone.
Takashi Y; Fukumoto S
Trends Endocrinol Metab; 2018 Nov; 29(11):755-767. PubMed ID: 30217676
[TBL] [Abstract][Full Text] [Related]
15. α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling.
Chen G; Liu Y; Goetz R; Fu L; Jayaraman S; Hu MC; Moe OW; Liang G; Li X; Mohammadi M
Nature; 2018 Jan; 553(7689):461-466. PubMed ID: 29342138
[TBL] [Abstract][Full Text] [Related]
16. FGF23-Klotho signaling axis in the kidney.
Erben RG; Andrukhova O
Bone; 2017 Jul; 100():62-68. PubMed ID: 27622885
[TBL] [Abstract][Full Text] [Related]
17. Klotho/FGF23 Axis in CKD.
Tsuchiya K; Nagano N; Nitta K
Contrib Nephrol; 2015; 185():56-65. PubMed ID: 26023015
[TBL] [Abstract][Full Text] [Related]
18. The parathyroid is a target organ for FGF23 in rats.
Ben-Dov IZ; Galitzer H; Lavi-Moshayoff V; Goetz R; Kuro-o M; Mohammadi M; Sirkis R; Naveh-Many T; Silver J
J Clin Invest; 2007 Dec; 117(12):4003-8. PubMed ID: 17992255
[TBL] [Abstract][Full Text] [Related]
19. FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells.
Suvannasankha A; Tompkins DR; Edwards DF; Petyaykina KV; Crean CD; Fournier PG; Parker JM; Sandusky GE; Ichikawa S; Imel EA; Chirgwin JM
Oncotarget; 2015 Aug; 6(23):19647-60. PubMed ID: 25944690
[TBL] [Abstract][Full Text] [Related]
20. Both FGF23 and extracellular phosphate activate Raf/MEK/ERK pathway via FGF receptors in HEK293 cells.
Yamazaki M; Ozono K; Okada T; Tachikawa K; Kondou H; Ohata Y; Michigami T
J Cell Biochem; 2010 Dec; 111(5):1210-21. PubMed ID: 20717920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
